A carregar...
Publicação
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 405.84 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
Descrição
Palavras-chave
Antimycobacterial Susceptibility Testing Breakpoints Antimicrobial resistance QR Microbiology RM Therapeutics. Pharmacology RA0421 Public health. Hygiene. Preventive Medicine Pulmonary and Respiratory Medicine Medical Laboratory Technology Infectious Diseases Microbiology (medical) Drug guides SDG 3 - Good Health and Well-being SDG 12 - Responsible Consumption and Production SDG 17 - Partnerships for the Goals